Compounding US FDA’s Problems: The High Stakes In GLP-1 Shortage Actions

 
• By Michael McCaughan
  
The FDA is facing a court challenge of its decision to end the shortage of brand GLP-1s. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance